A 2010 study of tiotropium challenged the notion that there is no place for LAAMs in asthma therapy.
The results suggest that LAAMs could be useful in treating uncontrolled asthma.
Long-acting anticholinergic medication (LAAM)--tiotropium is the only drug in this class on the market, but there are others in clinical trials--is the mainstay of therapy for chronic obstructive pulmonary disease.